Aims and scope
End of Life Journal is a peer-reviewed journal that publishes articles on all aspects of nursing practice relating to end-of-life care. It is primarily aimed at generalist nurses working in hospital, community and care home settings. However, many articles will also be of interest to the specialist palliative care audience. The journal focuses on care for patients with both malignant and non-malignant disease and their family and friends.
The journal publishes articles relating to clinical skills and symptom management as well as clinical reviews, ethics and the law, primary research and audit, clinical practice development, professional issues and debate. Each issue will have an article relating to communication skills. The journal is keen to publish nursing assignments and will help students to adapt their course work into articles.
The journal will include clinical skills, communication skills, clinical reviews, symptom management, psychological, spiritual, social and physical aspects of care, research/audit, clinical practice development, professional issues and debate along with assignments (we are happy to help people adapt their course work into articles).
End of Life Journal is published by BMJ and owned by St Christopher’s Hospice.
Time from submission to first decision
Time from acceptance to publication
44 days (online)
For all contact information please refer to the contact us page.
Please refer to the Instructions for authors
Rights and permissions
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Publishing Group is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.